Repligen Corporation
RGEN Healthcare Medical Instruments & Supplies
Repligen Corporation’s revenue for fiscal 2025 (year ended December 2025) was $738.3 million, up 16.4% from fiscal 2024. In the quarter to June 2026, revenue grew 11.9%, EPS fell 65.4%, free cash flow grew 27.1% and total debt rose 3.25%, each against the same quarter a year earlier.
Follow RGEN
Repligen Corporation (RGEN) Altman Z-score
Repligen Corporation's Altman Z-score for fiscal 2025 is 7.49, in the safe zone (above 2.99).
Altman Z-score, annual
Embed this chart
Annual newest first
| Period | Altman Z-score | Change (points) |
|---|---|---|
| FY2025 | 7.49 | 1.07 |
| FY2024 | 6.42 | (1.41) |
| FY2023 | 7.83 | (2.35) |
| FY2022 | 10.18 | (5.10) |
| FY2021 | 15.29 | (1.61) |
| FY2020 | 16.90 | 8.22 |
| FY2019 | 8.68 | (0.59) |
| FY2018 | 9.27 | 3.25 |
| FY2017 | 6.02 | (0.08) |
| FY2016 | 6.10 | (18.55) |
How fiscal 2025’s score is made up
| Component | This year | Year before | Result | Points |
|---|---|---|---|---|
| Working capital / total assets | 0.34 | — | 0.41 | |
| Retained earnings / total assets | 0.15 | — | 0.22 | |
| EBIT / total assets | 0.02 | — | 0.06 | |
| Market value of equity / total liabilities | 10.92 | — | 6.55 | |
| Sales / total assets | 0.25 | — | 0.25 | |
| Altman Z-score | Safe zone | 7.49 | ||
| Z″ Variant for non-manufacturing and asset-light companies (drops the sales/assets term, uses book equity) | Safe zone | 5.48 | ||
How the Altman Z-score works
Z = 1.2 × working capital ÷ total assets + 1.4 × retained earnings ÷ total assets + 3.3 × EBIT ÷ total assets + 0.6 × market value of equity ÷ total liabilities + 1.0 × revenue ÷ total assets (Altman, 1968). The market value of equity is the close on the last trading day of the fiscal year times weighted basic shares.
Z″ = 6.56 × working capital ÷ total assets + 3.26 × retained earnings ÷ total assets + 6.72 × EBIT ÷ total assets + 1.05 × book equity ÷ total liabilities (Altman, Hartzell and Peck, 1995), the variant for non-manufacturing and asset-light companies.
| Zone | Z | Z″ |
|---|---|---|
| Safe zone | above 2.99 | above 2.60 |
| Grey zone | 1.81–2.99 | 1.10–2.60 |
| Distress zone | below 1.81 | below 1.10 |
Not worked out for banks, insurers and REITs, whose balance sheets the model does not describe, nor when a figure is missing or there is no share price in the week to the fiscal year end.
Altman Z-score against peers
| Company | Altman Z-score |
|---|---|
| RGEN Repligen Corporation | 7.5× |
| ALGN Align Technology, Inc. compare | 4.7× |
| ATR AptarGroup, Inc. compare | 3.8× |
| COO The Cooper Companies, Inc. compare | 3.5× |
| SOLV Solventum Corporation compare | 2.2× |
| BAX Baxter International Inc. compare | 2.1× |
| TFX Teleflex Incorporated compare | 2.0× |
| AVTR Avantor, Inc. compare | 1.5× |
| BLCO Bausch + Lomb Corporation compare | 0.9× |
What Altman Z-score is
The Altman Z-Score weighs working capital, retained earnings, operating profit, market value and sales against assets and debts to gauge the risk of distress.
1.2 × working capital ÷ total assets + 1.4 × retained earnings ÷ total assets + 3.3 × EBIT ÷ total assets + 0.6 × market value of equity ÷ total liabilities + 1.0 × revenue ÷ total assets